These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 9740842)

  • 1. [Isotretinoin (Roaccutane) in women of childbearing age: failure of following prescription guidelines].
    Autret E; Radal M; Jonville-Béra AP; Goehrs JM
    Ann Dermatol Venereol; 1997; 124(8):518-22. PubMed ID: 9740842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Isotretinoin in childbearing women: compliance with strengthen warnings].
    Autret-Leca E; Jonville-Béra AP; Szafir D; Cissoko H; Boulkroun Y; Goehrs JM
    Ann Dermatol Venereol; 2000 Oct; 127(10):808-13. PubMed ID: 11060382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Isotretinoin: compliance with recommendations in childbearing women].
    Bensouda-Grimaldi L; Jonville-Béra AP; Mouret E; Elefant E; Dhellot H; Delmas C; Gouin T; Coste P; Autret-Leca E;
    Ann Dermatol Venereol; 2005 May; 132(5):415-23. PubMed ID: 15988352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continued occurrence of Accutane-exposed pregnancies.
    Honein MA; Paulozzi LJ; Erickson JD
    Teratology; 2001 Sep; 64(3):142-7. PubMed ID: 11514944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accutane-exposed pregnancies--California, 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Jan; 49(2):28-31. PubMed ID: 10680601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART program.
    Brinker A; Kornegay C; Nourjah P
    Arch Dermatol; 2005 May; 141(5):563-9. PubMed ID: 15897377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isotretinoin use and compliance with the Dutch Pregnancy Prevention Programme: a retrospective cohort study in females of reproductive age using pharmacy dispensing data.
    Teichert M; Visser LE; Dufour M; Rodenburg E; Straus SM; De Smet PA; Stricker BH
    Drug Saf; 2010 Apr; 33(4):315-26. PubMed ID: 20297863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Young women taking isotretinoin still conceive. Role of physicians in preventing disaster.
    Atanackovic G; Koren G
    Can Fam Physician; 1999 Feb; 45():289-92. PubMed ID: 10065298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pregnancy-prevention program in women of childbearing age receiving isotretinoin.
    Mitchell AA; Van Bennekom CM; Louik C
    N Engl J Med; 1995 Jul; 333(2):101-6. PubMed ID: 7777014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Exposure to isotretinoin during pregnancy in France: 25 years of follow-up].
    Rouzès A; Jonville-Béra AP
    Therapie; 2014; 69(1):53-63. PubMed ID: 24698189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare professional surveys to investigate the implementation of the isotretinoin Pregnancy Prevention Programme: a descriptive study.
    Crijns I; Mantel-Teeuwisse A; Bloemberg R; Pinas E; Straus S; de Jong-van den Berg L
    Expert Opin Drug Saf; 2013 Jan; 12(1):29-38. PubMed ID: 23163396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isotretinoin exposure during pregnancy: assessment of spontaneous reports in France.
    Autret-Leca E; Kreft-Jais C; Elefant E; Cissoko H; Darrouzain F; Grimaldi-Bensouda L; Attia S; Jonville-Béra AP
    Drug Saf; 2010 Aug; 33(8):659-65. PubMed ID: 20635824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA approves mandatory risk management program for isotretinoin.
    Cuzzell JZ
    Dermatol Nurs; 2005 Oct; 17(5):383. PubMed ID: 16294949
    [No Abstract]   [Full Text] [Related]  

  • 14. "Be smart, be safe, be sure". The revised Pregnancy Prevention Program for women on isotretinoin.
    Perlman SE; Leach EE; Dominguez L; Ruszkowski AM; Rudy SJ
    J Reprod Med; 2001 Feb; 46(2 Suppl):179-85. PubMed ID: 11255826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy.
    Schaefer C; Meister R; Weber-Schoendorfer C
    Arch Gynecol Obstet; 2010 Feb; 281(2):221-7. PubMed ID: 19444462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of compliance with isotretinoin PPP recommendations and exploration of reasons for non-compliance: Survey among French-speaking health care professionals and patients in Belgium.
    Lelubre M; Hamdani J; Senterre C; Amighi K; Peres M; Schneider MP; Bugnon O; De Vriese C
    Pharmacoepidemiol Drug Saf; 2018 Jun; 27(6):668-673. PubMed ID: 29726056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal exposure to isotretinoin-an international problem.
    Garcia-Bournissen F; Tsur L; Goldstein LH; Staroselsky A; Avner M; Asrar F; Berkovitch M; Straface G; Koren G; De Santis M
    Reprod Toxicol; 2008 Jan; 25(1):124-8. PubMed ID: 18077132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying pregnancies in insurance claims data: Methods and application to retinoid teratogenic surveillance.
    MacDonald SC; Cohen JM; Panchaud A; McElrath TF; Huybrechts KF; Hernández-Díaz S
    Pharmacoepidemiol Drug Saf; 2019 Sep; 28(9):1211-1221. PubMed ID: 31328328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compliance with pregnancy prevention programmes of isotretinoin in Europe: a systematic review.
    Crijns HJ; Straus SM; Gispen-de Wied C; de Jong-van den Berg LT
    Br J Dermatol; 2011 Feb; 164(2):238-44. PubMed ID: 20716214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the availability of the teratogenic drug isotretinoin outside the pregnancy prevention programme: a survey of e-pharmacies.
    Lagan BM; Dolk H; White B; Uges DR; Sinclair M
    Pharmacoepidemiol Drug Saf; 2014 Apr; 23(4):411-8. PubMed ID: 24493556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.